Curosurf

Curosurf

Active Ingredient:
Poractant Alfa
Origin:
EU

Buy Curosurf Poractant Alfa

Curosurf (Poractant Alfa) is a surfactant replacement therapy used to treat respiratory distress in premature infants. This product helps improve lung function and oxygenation, often administered via endotracheal tube.

Manufacturer / TM Owner

Chiesi España S.A.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Curosurf is primarily used to manage respiratory distress syndrome (RDS) in premature infants. This condition occurs when the lungs lack sufficient surfactant, a substance that keeps the air sacs open. By providing exogenous surfactant, Curosurf aids in reducing surface tension within the lungs, facilitating easier breathing and improving oxygen levels. It is typically administered directly into the lungs via an endotracheal tube.

Side Effects

  • Curosurf works by replacing the natural surfactant in the lungs, which helps to reduce surface tension and improve lung compliance. This can lead to better oxygenation and reduced respiratory effort in premature infants. The effects are generally observed shortly after administration, contributing to improved respiratory function.

Precautions & Warnings

  • Curosurf should be administered by healthcare professionals experienced in neonatal intensive care. It is essential to follow proper handling and storage guidelines to maintain its efficacy. Monitoring the infant's respiratory status and oxygen levels is crucial during and after administration to ensure optimal outcomes.

Avoid Interactions

  • Curosurf is generally used in a controlled medical setting, and interactions with other medications are not commonly reported. However, it is important to inform healthcare providers about any other treatments the infant is receiving to avoid potential complications. Always consult a healthcare professional for specific advice.

References

Frequently Asked Questions

Curosurf is used to treat respiratory distress syndrome (RDS) in premature infants by providing exogenous surfactant to improve lung function.

Curosurf is typically administered directly into the lungs via an endotracheal tube by healthcare professionals.

Curosurf helps reduce surface tension in the lungs, improving oxygenation and reducing respiratory effort in premature infants.

Curosurf should be handled and administered by trained healthcare professionals, with proper monitoring of the infant's respiratory status.

Interactions with other medications are not commonly reported, but it is important to inform healthcare providers about all treatments the infant is receiving.

Published by GNH India Pharmaceuticals Limited

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT